Kenvue (KVUE) Debuts on Fortune 500 List

Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced it has made the prestigious Fortune 500 list for the first time since becoming a fully independent company. With 2024 full year sales of $15.5 billion, Kenvue is listed at number 281. The company’s debut is a testament to the power of its iconic brands and deep commitment to improving the health and well-being of consumers globally through science-backed, insights-led innovation.

“Being named to the Fortune 500 list marks a significant milestone for Kenvue,” said Thibaut Mongon, Chief Executive Officer. “Recognitions like this validate the hard work and dedication of our Kenvuers, while also further propelling our desire to become the undisputed global leader in consumer health. We are honored to join this elite group of companies and look forward to continuing our journey of growth and impact.”

Operating in over 165 countries worldwide, Kenvue is comprised of a curated portfolio of Essential Health, Self Care, and Skin Health & Beauty brands reaching approximately 1.2 billion people daily. Its global workforce of more than 20,000 purpose-led, values-based Kenvuers are driven to make a meaningful impact on the health of people and the planet. By combining the power of science with deep human insights and cutting-edge technology, Kenvue is poised to use its size and scale as a Fortune 500 company to take a leadership role in the wellness revolution - placing its products and solutions at the center of everyday care rituals, today and into the future.

Now in its 71st year, the Fortune 500 is Fortune magazine's annual list of the 500 largest U.S. companies ranked by total revenues for their respective fiscal years. The list is compiled using the most recent revenue figures and includes both public and private companies.

You May Also Be Interested In

• Active options: NVDA TSLA AMZN AAPL MSTR SPCX MU PLTR MSFT WEN SOFI
• Bitcoin hits session low under $59,283
• Active options: INTC META ASST RUN NFLX AVGO HOOD ORCL IREN